Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder

NCT02294305 is registered in ClinicalTrials.gov with The Medical Research Network as lead sponsor.

NCT NCT02294305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02294305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Lead sponsor
The Medical Research Network
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2014
Completion date
November 30, 2016
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, social anxiety disorder